234 related articles for article (PubMed ID: 9733833)
1. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
Wang CT; Lai HY; Li JJ
J Virol; 1998 Oct; 72(10):7950-9. PubMed ID: 9733833
[TBL] [Abstract][Full Text] [Related]
2. Assembly and release of human immunodeficiency virus type 1 Gag proteins containing tandem repeats of the matrix protein coding sequences in the matrix domain.
Wang CT; Chen SS; Chiang CC
Virology; 2000 Dec; 278(1):289-98. PubMed ID: 11112503
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
4. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
5. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
6. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
Ono A; Demirov D; Freed EO
J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
8. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
Melamed D; Mark-Danieli M; Kenan-Eichler M; Kraus O; Castiel A; Laham N; Pupko T; Glaser F; Ben-Tal N; Bacharach E
J Virol; 2004 Sep; 78(18):9675-88. PubMed ID: 15331700
[TBL] [Abstract][Full Text] [Related]
9. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.
Yu XF; Matsuda Z; Yu QC; Lee TH; Essex M
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3171-9. PubMed ID: 8847526
[TBL] [Abstract][Full Text] [Related]
10. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
Chiu HC; Yao SY; Wang CT
J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
[TBL] [Abstract][Full Text] [Related]
11. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
Wang CT; Zhang Y; McDermott J; Barklis E
J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966
[TBL] [Abstract][Full Text] [Related]
12. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Joshi A; Nagashima K; Freed EO
J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
[TBL] [Abstract][Full Text] [Related]
13. Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
Martin JL; Mendonça LM; Marusinec R; Zuczek J; Angert I; Blower RJ; Mueller JD; Perilla JR; Zhang W; Mansky LM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695435
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
Ono A; Freed EO
J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
[TBL] [Abstract][Full Text] [Related]
16. Particle size determinants in the human immunodeficiency virus type 1 Gag protein.
Garnier L; Ratner L; Rovinski B; Cao SX; Wills JW
J Virol; 1998 Jun; 72(6):4667-77. PubMed ID: 9573230
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.
Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M
J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672
[TBL] [Abstract][Full Text] [Related]
18. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.
Wang CT; Barklis E
J Virol; 1993 Jul; 67(7):4264-73. PubMed ID: 7685414
[TBL] [Abstract][Full Text] [Related]
19. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.
Morikawa Y; Zhang WH; Hockley DJ; Nermut MV; Jones IM
J Virol; 1998 Sep; 72(9):7659-63. PubMed ID: 9696871
[TBL] [Abstract][Full Text] [Related]
20. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.
Zhang Y; Barklis E
J Virol; 1997 Sep; 71(9):6765-76. PubMed ID: 9261401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
